Inari Medical, Inc. Kaplan Fox Files Class Action to Recover Losses for Investors Who Purchased Common Stock of Inari Medical, Inc. (NasdaqGS: NARI) for an Expanded Class Period—March 10, 2021 through February 28, 2024… Read More
Barclays iPath Series B S&P 500 VIX Short-Term Futures ETN Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) and Co-Counsel Sperling & Slater LLC has filed a class action suit in the United States District Court for the Southern District of New York against Barclays PLC, Barclays Bank PLC, James E. Staley, Tushar Morzaria and C.S. Venkatakrishnan (“Defendants”). … Read More
Charles River Laboratories International, Inc. A complaint was filed against Charles River Laboratories International, Inc. alleging the company and its executives concealed illegal importation of nonhuman primates used for research. The complaint was filed in Massachusetts federal court against Charles River, James Foster, David Smith and Flavia Pease. This is a class action on behalf of persons and entities that purchased or otherwise acquired Charles River securities between May 5, 2020 and February 21, 2023, inclusive (the Class Period)…. Read More
Digital Currency Group, Inc. On November 13, 2023, Lead Plaintiffs filed an amended complaint against Digital Currency Group, Inc., Barry Silbert, Glenn Hutchins, Lawrence Lenihan, Michael Kraines, Mark Murphy, Soichiro “Michael” Moro, and Derar Islim alleging violations of the Securities Act of 1933, the Securities Exchange Act of 1934, and violations of New York and Connecticut consumer protection statutes. A copy of the November 13, 2023 amended complaint can be viewed here…. Read More
Spectrum Pharmaceuticals, Inc. Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has filed a proposed class action suit in the United States District Court for the Southern District of New York against Spectrum Pharmaceuticals, Inc. (“Spectrum” or the “Company”) (NasdaqGS: SPPI), Thomas J. Riga, the Company’s Chief Executive Officer, and a member of the Company’s Board of Directors, Francois J. Lebel, the Company’s Chief Medical Officer, and Nora E. Brennan, the Company’s Chief Financial Officer. … Read More
Co-Diagnostics, Inc. Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has filed a class action suit in the United States District Court for the Southern District of New York against Co-Diagnostics, Inc. (“Co-Dx” or the “Company”) (NASDAQ: CODX); Dwight H. Egan, the Company’s Chief Executive Officer, President and Chairman of the Board; and Brian L. Brown, the Company’s Chief Financial Officer and Secretary (“Defendants”)…. Read More
Vale SA Kaplan Fox is the court-appointed lead counsel in this securities class action on behalf of all purchasers of Geron common stockbetween March 19, 2018 and September 26, 2018, inclusive (the “Class Period”), who weredamaged thereby (the “Class”)… Read More
Geron Corporation Kaplan Fox is the court-appointed lead counsel in this securities class action on behalf of all purchasers of Geron common stock between March 19, 2018 and September 26, 2018, inclusive (the “Class Period”), who were damaged thereby (the “Class”)…. Read More
